-
Sarepta Therapeutics (NASDAQ:SRPT) Earns "Sell" Rating from HC Wainwright
Source: Buzz FX / 28 Feb 2025 08:47:13 America/New_York
Sarepta Therapeutics (NASDAQ:SRPT) Earns "Sell" Rating from HC Wainwright Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "sell" rating reaffirm
Read more...